Table 2.
Patient | Surgery before PRE-1 | Tumor | Recurrence at PRE-2 | |||||
---|---|---|---|---|---|---|---|---|
Entity | WHO grade | IDH mutation | 1p19q codeletion | Location | Subcortical | |||
1 | N | GBM | IV | N | – | aSMG | N | N |
2 | N | AA | III | Y | N | insular | Y | Y |
3 | Y | DA | II | Y | N | insular | Y | N |
4 | N | GBM | IV | N | - | mMFG/pMFG | Y | Y |
5 | Y | AA | III | Y | N | pMFG/opIFG | Y | Y |
6 | Y | AA | III | N | N | pMTG | N | Y |
7 | N | GBM | IV | N | – | aSMG | N | Y |
8 | N | GBM | IV | – | – | STG | Y | Y |
9 | Y | AA | III | Y | N | pMFG/opIFG | Y | N |
10 | N | GBM | IV | N | – | STG | Y | Y |
The table shows the tumor characteristics of all included patients and the detailed location of each tumor (Y, yes, N, no; DA, diffuse astrocytoma, AA, anaplastic astrocytoma, GBM, glioblastoma; aSMG, anterior supramarginal gyrus, mMFG, middle middle frontal gyrus; pMFG, posterior middle frontal gyrus; opIFG, opercular inferior frontal gyrus; pMTG, posterior middle temporal gyrus; STG, superior temporal gyrus).